Regression of Oral Leukoplakia With  -Tocopherol: A Community Clinical Oncology Program Chemoprevention Study

A study sought to evaluate the toxicity and efficacy of alpha-tocopherol in patients with oral leukoplakia. The feasibility of performing chemoprevention trials through the Community Clinical Oncology Program is discussed.

Saved in:
Bibliographic Details
Published in:JNCI : Journal of the National Cancer Institute 1993-01, Vol.85 (1), p.44-47
Main Authors: Benner, S. E., Winn, R. J., Lippman, S. M., Poland, J., Hansen, K. S., Luna, M. A., Hong, W. K.
Format: Article
Language:English
Subjects:
Cancer
Drug therapy
Medical research
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A study sought to evaluate the toxicity and efficacy of alpha-tocopherol in patients with oral leukoplakia. The feasibility of performing chemoprevention trials through the Community Clinical Oncology Program is discussed.
ISSN:0027-8874
1460-2105
DOI:10.1093/jnci/85.1.44